tradingkey.logo

Agape ATP Corp

ATPC
0.049USD
-0.014-22.22%
Close 02/06, 16:00ETQuotes delayed by 15 min
2.45MMarket Cap
LossP/E TTM

Agape ATP Corp

0.049
-0.014-22.22%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Agape ATP Corp

Currency: USD Updated: 2026-02-06

Key Insights

Agape ATP Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 152 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is low.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Agape ATP Corp's Score

Industry at a Glance

Industry Ranking
152 / 205
Overall Ranking
528 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Agape ATP Corp Highlights

StrengthsRisks
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.32M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.32M.
Overvalued
The company’s latest PE is -0.19, at a high 3-year percentile range.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Agape ATP Corp is 6.12, ranking 172 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 370.59K, representing a year-over-year increase of 11.86%, while its net profit experienced a year-over-year increase of 15.15%.

Score

Industry at a Glance

Previous score
6.12
Change
0

Financials

6.25

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.86

Operational Efficiency

4.65

Growth Potential

5.77

Shareholder Returns

7.07

Agape ATP Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Agape ATP Corp is 6.73, ranking 154 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.19, which is 0.00% below the recent high of -0.19 and -39903.71% above the recent low of -76.57.

Score

Industry at a Glance

Previous score
6.73
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 152/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Agape ATP Corp. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Agape ATP Corp is 2.19, ranking 199 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.11 and the support level at 0.01, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
2.12
Change
0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.040
Neutral
RSI(14)
27.594
Sell
STOCH(KDJ)(9,3,3)
12.527
Oversold
ATR(14)
0.015
High Vlolatility
CCI(14)
-247.802
Oversold
Williams %R
94.023
Oversold
TRIX(12,20)
-4.684
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.070
Sell
MA10
0.076
Sell
MA20
0.079
Sell
MA50
0.332
Sell
MA100
0.790
Sell
MA200
1.169
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Lesser Panda Ltd
3.68M
--
Global Fartech Ltd
3.45M
--
Nexus Investments Group Ltd
3.04M
--
Oceanic Equity Partner Ltd
3.03M
--
Blue Horizon Capital Ltd
3.03M
--
Global Ascend Ventures Ltd
3.02M
--
Vanguard Development Holdings Ltd
3.02M
--
Evergreen Strategic Capital Holding Ltd
3.01M
--
Choong (How Kok)
980.45K
+0.06%
Citadel Advisors LLC
65.13K
+95.70%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Agape ATP Corp is 1.04, ranking 202 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
1.04
Change
0
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+98.00%
240-Day Volatility
+238.18%

Return

Best Daily Return
60 days
+164.56%
120 days
+164.56%
5 years
--
Worst Daily Return
60 days
-94.83%
120 days
-94.83%
5 years
--
Sharpe Ratio
60 days
+0.18
120 days
+0.11
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+98.00%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.99
3 years
--
5 years
--
Skewness
240 days
+4.46
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
+238.18%
5 years
--
Standardised True Range
240 days
+244.48%
5 years
--
Downside Risk-Adjusted Return
120 days
+17.74%
240 days
+17.74%
Maximum Daily Upside Volatility
60 days
+451.02%
Maximum Daily Downside Volatility
60 days
+289.72%

Liquidity

Average Turnover Rate
60 days
+0.10%
120 days
+1.31%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--

Peer Comparison

Healthcare Equipment & Supplies
Agape ATP Corp
Agape ATP Corp
ATPC
3.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI